Department of Surgery, School of Medicine, Kyungpook National University, Daegu, Republic of Korea; Department of Surgery, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea.
Department of Surgery, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea.
Eur J Surg Oncol. 2024 Sep;50(9):108517. doi: 10.1016/j.ejso.2024.108517. Epub 2024 Jun 27.
Microscopically positive resection margin (RM) following curative surgery has been linked to disease recurrence in gastric cancer (GC), but the impact of microscopically negative but close RM (CRM) remains unclear. This study aimed to evaluate the prognostic implications of a CRM of ≤0.5 cm in GC patients.
A retrospective review of the institutional GC database identified 1958 patients who underwent curative gastrectomy for pathologically proven GC between January 2011 and December 2015. The patients were categorized into CRM (RM ≤0.5 cm) and sufficient RM (SRM, RM >0.5 cm) groups. The impact of CRM on recurrence-free survival (RFS) and overall survival (OS) was analyzed compared to the SRM group.
The cohort comprised 1264 patients with early GC (EGC, 64.6%) and 694 with advanced GC (AGC, 35.4%). Forty-four patients (2.2%) had RM of ≤0.5 cm. CRM was associated with worse RFS in AGC (5-year RFS in the CRM vs. SRM groups; 41.6% vs. 68.7%, p = 0.011); however, the effect on OS was not significant (p = 0.159). Multivariate analysis revealed that CRM was an independent prognostic factor for RFS (hazard ratio [HR] 2.035, 95% confidence interval [CI] 1.097-3.776). In AGC, the locoregional recurrence rate was significantly higher in the CRM group than in the SRM group (15.4% vs. 4.9%, p = 0.044).
CRM of ≤0.5 cm was a significant prognostic factor for RFS in GC patients and was associated with a significant increase in locoregional recurrence in AGC.
根治性手术后显微镜下阳性切缘(RM)与胃癌(GC)的疾病复发有关,但显微镜下阴性但接近 RM(CRM)的影响仍不清楚。本研究旨在评估 GC 患者 CRM≤0.5cm 的预后意义。
回顾性分析机构 GC 数据库,共纳入 1958 例 2011 年 1 月至 2015 年 12 月期间经病理证实为 GC 行根治性胃切除术的患者。将患者分为 CRM(RM≤0.5cm)和足够 RM(SRM,RM>0.5cm)组。与 SRM 组相比,分析 CRM 对无复发生存率(RFS)和总生存(OS)的影响。
该队列包括 1264 例早期 GC(EGC,64.6%)和 694 例晚期 GC(AGC,35.4%)患者。44 例(2.2%)RM≤0.5cm。CRM 与 AGC 的 RFS 较差相关(CRM 与 SRM 组的 5 年 RFS;41.6% vs. 68.7%,p=0.011);然而,对 OS 的影响不显著(p=0.159)。多变量分析显示 CRM 是 RFS 的独立预后因素(风险比[HR]2.035,95%置信区间[CI]1.097-3.776)。在 AGC 中,CRM 组的局部区域复发率明显高于 SRM 组(15.4% vs. 4.9%,p=0.044)。
CRM≤0.5cm 是 GC 患者 RFS 的显著预后因素,与 AGC 中局部区域复发率的显著增加相关。